FDA Clears First Drug for Rare Inherited Form of Rickets FDA Clears First Drug for Rare Inherited Form of Rickets

Burosumab (Crysvita) targets the underlying cause of X-linked hypophosphatemia and is indicated for adults and children age 1 year and older.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news